Because HMGA2 was shown to protect pancreatic cancer cells from DNA damage-induced apoptosis, elevating MMP-14 expression will consequently reduce the effects of gemcitabine by increasing the expression of MMP-14. Here, MMP14 is linked to familial pancreatic carcinoma.